 |
| In This Issue |  Top |
|
 |
|
| PDF |
|
| Editorials | Top |
|
|
|
Trials, tribulations and diversification p1411
doi:10.1038/nbt1203-1411a
Full text | PDF
(54K)
|
|
|
|
Beyond belief p1411
doi:10.1038/nbt1203-1411b
Full text | PDF
(54K)
|
|
| News | Top |
|
|
|
Companies jostle for access to public markets pp1413 - 1414
Aaron Bouchie
doi:10.1038/nbt1203-1413
Full text | PDF
(287K)
|
|
|
|
Germany biotech gets second chance pp1414 - 1415
Cormac Sheridan
doi:10.1038/nbt1203-1414
Full text | PDF
(158K)
|
|
|
|
Regulators equivocate on safety of clones pp1415 - 1416
Kendall Powell
doi:10.1038/nbt1203-1415
Full text | PDF
(272K)
|
|
|
|
Biotechs await single European financial market p1417
Sabine Louët
doi:10.1038/nbt1203-1417a
Full text | PDF
(150K)
|
|
|
|
US bioethics committee weighs in pp1417 - 1418
Jeffrey L. Fox
doi:10.1038/nbt1203-1417b
Full text | PDF
(417K)
|
|
|
|
Europe responds to UK's GM field trials pp1418 - 1419
Peter Mitchell
doi:10.1038/nbt1203-1418
Full text | PDF
(341K)
|
|
|
|
EU wrangles internally over safety of donated tissues and cells p1420
Peter Vermij
doi:10.1038/nbt1203-1420
Full text | PDF
(289K)
|
|
 |
|
| In Brief |
|
|
|
News In Brief pp1421 - 1423
doi:10.1038/nbt1203-1421
Full text | PDF
(103K)
|
|
|
|
| News Feature |
|
|
|
Ultrafast DNA sequencing pp1425 - 1427
Jim Kling
doi:10.1038/nbt1203-1425
Abstract | Full text | PDF
(202K)
|
|
| Opinion and Comment | Top |
|
|
|
| Correspondence |
|
|
|
UK field-scale evaluations answer wrong questions pp1429 - 1430
Bruce Chassy, Catherine Carter, Martina McGloughlin, Alan McHughen, Wayne Parrott, Christopher Preston, Richard Roush, Anthony Shelton
& Steven H Strauss
doi:10.1038/nbt1203-1429
Full text | PDF
(72K)
|
|
|
|
| Commentary |
|
|
|
Vox populi and public policy: why should we care? pp1431 - 1432
Henry I Miller
doi:10.1038/nbt1203-1431
Full text | PDF
(298K)
|
|
|
|
Time to drop the language of 'consensus' p1433
Leigh Turner
doi:10.1038/nbt1203-1433
Full text | PDF
(69K)
|
|
|
|
Biotechnology and the UN's Millennium Development Goals pp1434 - 1436
Tara Acharya, Abdallah S Daar
& Peter A Singer
doi:10.1038/nbt1203-1434
Full text | PDF
(85K)
|
|
|
|
| Fool's Corner |
|
|
|
Biotech IPOs: handle with care p1437
Tom Jacobs
doi:10.1038/nbt1203-1437
Full text | PDF
(58K)
|
|
|
|
| Book Review |
|
|
|
A patently negative view of industry pp1439 - 1440
Reviewed by: Philip Grubb
doi:10.1038/nbt1203-1439
Full text | PDF
(109K)
|
|
| Feature | Top |
|
|
|
Unlocking the money-making potential of RNAi pp1441 - 1446
Ken Howard
doi:10.1038/nbt1203-1441
Abstract | Full text | PDF
(409K)
|
|
| News and Views | Top |
|
|
|
Fluorescent proteins with ties that bind pp1447 - 1448
Timothy A Ryan
doi:10.1038/nbt1203-1447
Abstract | Full text | PDF
(303K)
See also: Research by Zeytun et al. |
|
|
|
Mending the message pp1448 - 1449
Mariano A Garcia-Blanco
doi:10.1038/nbt1203-1448
Abstract | Full text | PDF
(272K)
See also: Research by Deidda et al. |
|
|
|
Bt-resistance management—theory meets data pp1450 - 1451
Fred Gould
doi:10.1038/nbt1203-1450
Abstract | Full text | PDF
(123K)
See also: Research by Zhao et al. |
|
|
|
Cloning by numbers pp1451 - 1452
Louis-Marie Houdebine
doi:10.1038/nbt1203-1451
Abstract | Full text | PDF
(189K)
|
|
|
|
UK farm-scale evaluations of transgenic herbicide-tolerant crops pp1453 - 1454
David A Andow
doi:10.1038/nbt1203-1453
Abstract | Full text | PDF
(96K)
|
|
|
|
Research notes p1455
doi:10.1038/nbt1203-1455
Full text | PDF
(97K)
|
|
| Research | Top |
|
|
|
| Review |
|
|
|
Approaches for the sequence-specific knockdown of mRNA pp1457 - 1465
Lisa J Scherer
& John J Rossi
Published online: 26 November 2003 | doi:10.1038/nbt915
Abstract | Full text | PDF
(982K)
|
|
|
|
| Brief Communications |
|
|
|
Antibiotic optimization via in vitro glycorandomization pp1467 - 1469
Xun Fu, Christoph Albermann, Jiqing Jiang, Jianchun Liao, Changsheng Zhang
& Jon S Thorson
Published online: 09 November 2003 | doi:10.1038/nbt909
Abstract | Full text | PDF
(242K)
| Supplementary Information |
|
|
|
Sialylated endogenous glycoconjugates in plant cells pp1470 - 1471
Miti M Shah, Kazuhito Fujiyama, C Robert Flynn
& Lokesh Joshi
Published online: 09 November 2003 | doi:10.1038/nbt912
Abstract | Full text | PDF
(245K)
| Supplementary Information |
|
|
|
| Articles |
|
|
|
Retraction: Fluorobodies combine GFP fluorescence with the binding
characteristics of antibodies pp1473 - 1479
Ahmet Zeytun, Andreas Jeromin, Bethe A Scalettar, Geoffrey S Waldo
& Andrew RM Bradbury
Published online: 09 November 2003 | doi:10.1038/nbt911
Abstract | Full text | PDF
(1,886K)
| Supplementary Information
See also: News and Views by Ryan |
|
|
|
An engineered multidomain bactericidal peptide as a model for targeted antibiotics against specific bacteria pp1480 - 1485
Xiao-Qing Qiu, He Wang, Xiao-Fong Lu, Jie Zhang, Sheng-Fu Li, Gang Cheng, Lin Wan, Li Yang, Jun-Yong Zuo, Yu-Qi Zhou, Hai-Yun Wang, Xin Cheng, Su-Hua Zhang, Zheng-Rong Ou, Zi-Cheng Zhong, Jing-Qiu Cheng, You-Ping Li
& George Y Wu
Published online: 16 November 2003 | doi:10.1038/nbt913
Abstract | Full text | PDF
(661K)
|
|
|
|
Design of multivalent complexes using the barnase barstar module pp1486 - 1492
Sergey M Deyev, Robert Waibel, Ekaterina N Lebedenko, August P Schubiger
& Andreas Plückthun
Published online: 23 November 2003 | doi:10.1038/nbt916
Abstract | Full text | PDF
(1,612K)
| Supplementary Information |
|
|
|
Transgenic plants expressing two Bacillus thuringiensis toxins delay insect resistance evolution pp1493 - 1497
Jian-Zhou Zhao, Jun Cao, Yaxin Li, Hilda L Collins, Richard T Roush, Elizabeth D Earle
& Anthony M Shelton
Published online: 09 November 2003 | doi:10.1038/nbt907
Abstract | Full text | PDF
(131K)
See also: News and Views by Gould |
|
|
|
| Letters |
|
|
|
An archaeal endoribonuclease catalyzes cis- and trans- nonspliceosomal splicing in mouse cells pp1499 - 1504
Giancarlo Deidda, Nicoletta Rossi
& Glauco P Tocchini-Valentini
Published online: 02 November 2003 | doi:10.1038/nbt908
Abstract | Full text | PDF
(409K)
| Supplementary Information
See also: News and Views by Garcia-Blanco |
|
|
|
Genetically targeted chromophore-assisted light inactivation pp1505 - 1508
Oded Tour, Rene M Meijer, David A Zacharias, Stephen R Adams
& Roger Y Tsien
Published online: 16 November 2003 | doi:10.1038/nbt914
Abstract | Full text | PDF
(846K)
| Supplementary Information |
|
|
|
Analyzing antibody specificity with whole proteome microarrays pp1509 - 1512
Gregory A Michaud, Michael Salcius, Fang Zhou, Rhonda Bangham, Jaclyn Bonin, Hong Guo, Michael Snyder, Paul F Predki
& Barry I Schweitzer
Published online: 09 November 2003 | doi:10.1038/nbt910
Abstract | Full text | PDF
(372K)
| Supplementary Information |
|
|
|
| Errata |
|
|
|
Why biotech don't pay dividends−yet p1513
Tom Jacobs
doi:10.1038/nbt1203-1513a
Full text | PDF
(43K)
|
|
|
|
New biotech hubs may emerge as industry matures p1513
Paroma Basu
doi:10.1038/nbt1203-1513b
Full text | PDF
(43K)
|
|
|
|
| Corrigenda |
|
|
|
Invention and commercialization in optical bioimaging p1513
Daniel L. Farkas
doi:10.1038/nbt1203-1513c
Full text | PDF
(43K)
|
|
| Resources | Top |
|
|
|
| Patents |
|
|
|
The patent gamble: strategic insights for playing the worldwide patent game pp1515 - 1517
William A Barrett
doi:10.1038/nbt1203-1515
Abstract | Full text | PDF
(69K)
|
|
|
|
Recent patent applications relating to biological separations p1519
doi:10.1038/nbt1203-1519
Full text | PDF
(30K)
|
|
|
|
| People |
|
|
|
People p1521
doi:10.1038/nbt1203-1521
Full text | PDF
(53K)
|
|
|
|
| New on the Market |
|
|
|
Bioseparation & Antibodies p1523
doi:10.1038/nbt1203-1523
Full text | PDF
(256K)
|
|
| Naturejobs | Top |
|
|
|
| Careers and Recruitment |
|
|
|
Toward an integrated biotechnological engineering education program: a Canadian perspective pp1525 - 1527
Patrick Vermette, Pierre Proulx
& Bernard Marcos
doi:10.1038/nbt1203-1525
Abstract | Full text | PDF
(80K)
|
|
|
Top |
|
|
